Cover Image

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats

Context Atorvastatin (ATV) and QiShenYiQi pills (QSYQ), a Chinese patent medicine, are often co-prescribed to Chinese cardiovascular patients. The effects of QSYQ on the pharmacokinetics of ATV have not been studied. Objective We investigated the influence of QSYQ on the pharmacokinetics of ATV and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Congyang Ding (Author), Yajing Li (Author), Xiao Li (Author), Lu Meng (Author), Ran Fu (Author), Xiaonan Wang (Author), Ying Li (Author), Yinling Ma (Author), Zhanjun Dong (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
by: Shichao Lv, et al.
Published: (2022)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions
by: Chen JR, et al.
Published: (2015)

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction
by: Zhichao Liu, et al.
Published: (2024)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
by: Yule Wang, et al.
Published: (2021)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
by: Gulinigaer Anwaier, et al.
Published: (2022)

Uncovering the mechanisms of Yi Qi Tong Qiao Pill in the treatment of allergic rhinitis based on Network target analysis
by: Boyang Wang, et al.
Published: (2023)

Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach
by: Zhong Y, et al.
Published: (2023)

Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
by: Yuanyuan Zhong, et al.
Published: (2022)

The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats
by: Xiao Yu, et al.
Published: (2017)

ShenQiWan ameliorates renal injury in type 2 diabetic mice by modulating mitochondrial fusion and endoplasmic reticulum stress
by: Wei Xiong, et al.
Published: (2023)

Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
by: Juan Gao, et al.
Published: (2024)

Qi stagnation and qi deficiency are associated with depression in college students
by: Wang Xinzhu, et al.
Published: (2024)

Mechanism of action of Bu Zhong Yi Qi Decoction in the treatment of chronic fatigue syndrome based on network pharmacology and molecular docking
by: Jie Zhang, et al.
Published: (2022)

ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
by: Hongbo Zhang, et al.
Published: (2019)

The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure
by: Shichao Lv, et al.
Published: (2022)

Pediatric Quality Improvement (QI) Virtual Practicum: Adapting a QI Simulator
by: Celia Greenlaw, et al.
Published: (2020)

Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome
by: Wei-jian Zhang, et al.
Published: (2020)

Network pharmacology and experimental evidence reveal the protective mechanism of Yi-Qi Cong-Ming decoction on age-related hearing loss
by: Yi-Fang Yang, et al.
Published: (2022)

Target Identification of Active Constituents of Shen Qi Wan to Treat Kidney Yang Deficiency Using Computational Target Fishing and Network Pharmacology
by: Jie Ying Zhang, et al.
Published: (2019)

Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation
by: Yongwei Nie, et al.
Published: (2022)

Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway
by: Zhao M, et al.
Published: (2024)

Qi, Return to Bodily Experience: A New Perspective of Qi and Qigong Experience Research
by: Xinzhe Huang
Published: (2020)

Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
by: Qiaoru Wu, et al.
Published: (2022)

Protective Effects and Active Ingredients of Yi-Qi-Fu-Mai Sterile Powder Against Myocardial Oxidative Damage in Mice
by: Yu-Qing Wang, et al.
Published: (2013)

The Effectiveness and Safety of Yi Shen Juan Bi Pill on Rheumatoid Arthritis: a Protocol for Systematic Review and/or Meta-Analysis
by: Gyoungeun Park, et al.
Published: (2024)

Simultaneous determination of nineteen major components in Qi She Pill by ultra-high-performance liquid chromatography-tandem mass spectrometry
by: Zhongliang Zhang, et al.
Published: (2014)

Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro
by: Ya Xia, et al.
Published: (2021)

Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
by: Huihui Xu, et al.
Published: (2022)

A complementary method for detecting qi vacuity
by: Li Shu-Fang, et al.
Published: (2009)

Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP-VPAC2 signalling pathway
by: Muhua Huang, et al.
Published: (2021)

A Clinical Study on the Effects of Dong-Qi Acupuncture Treatment for Patents with low back pain and sciatica
by: Lee Kwang-Ho, et al.
Published: (2005)

The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters
by: Wenjie Huang, et al.
Published: (2022)

Yi Qi Jie Du Decoction Inhibits Proliferation and Induces Apoptosis of Nasopharyngeal Carcinoma Stem Cells Through Mitochondrial Apoptosis Pathway
by: Zhou Fang-Liang, et al.
Published: (2019)

Parental use of the term "Hot Qi" to describe symptoms in their children in Hong Kong: a cross sectional survey "Hot Qi" in children
by: Chan Danny, et al.
Published: (2006)

On the qi deficiency in traditional Chinese medicine
by: Hui-Chu Chiang, et al.
Published: (2014)

Ren-Shen-Bu-Qi decoction alleviates exercise fatigue through activating PI3K/AKT/Nrf2 pathway in mice
by: Yangyang Chen, et al.
Published: (2024)

Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro
by: Feixia Wang, et al.
Published: (2021)